Catalyst Wire Dossier Catalyst Wire Dossier

Afqlir

aflibercept · Sandoz GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Afqlir, covering 2026-03-03 to 2026-03-03. Get the full timeline:

Most recent: EMA Authorised: Afqlir (aflibercept) — Sandoz GmbH

See pricing